🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT05030259
Recruiting Observational

The Research About the ACS After Femoropopliteal Arterial Injuries

NCT05030259 · tracked via the Priya Life Science China tracker
Sponsor
Hebei Medical University Third Hospital
Phase
Observational
Started
2021-09-01
Last updated
2021-09-01

Condition(s) studied

Acute Compartment Syndrome

Investigational drug(s) / intervention(s)

fasciotomy

fasciotomy: To perform fasciotomy

Study summary

Crural Compartment syndrome is a well-known sequela after femoropopliteal arterial injuries in the lower extremity, particularly when there has been a long period of ischemia,need for ligation of a major vein, or when there is severe associated soft tissue.There is conteoversy in the treatment.

Eligibility

Sex
ALL
Min age
18 Years
Max age
Healthy volunteers
No
Inclusion Criteria: * patients with femoropopliteal arterial injuries * patients older than 18 years Exclusion Criteria: * Patients who did not survive to discharge * Patients with primary amputation * patients younger than 18 years

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
the Third Hospital of Hebei Medical Univesity Shijiazhuang Hebei Recruiting

More Hebei Medical University Third Hospital trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05030259 on ClinicalTrials.gov ↗ ← All trials in China